<DOC>
	<DOCNO>NCT02341794</DOCNO>
	<brief_summary>The purpose study investigate effect rosuvastatin treatment degree intracranial arterial stenosis .</brief_summary>
	<brief_title>Rosuvastatin Treatment Intracranial Arterial Stenosis Based Magnetic Resonance Angiography</brief_title>
	<detailed_description>The purpose study investigate effect rosuvastatin treatment degree intracranial arterial stenosis two year . Dyslipidemia patient intracranial arterial stenosis enrol informed consent study . Rosuvastatin ( 5mg ) orally administer daily . Dose rosuvastatin adjust control serum LDL-c level 1.8mmol/L . Primary outcome progression intracranial stenosis magnetic resonance angiography ( MRA ) two year .</detailed_description>
	<mesh_term>Intracranial Arterial Diseases</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Male female patient 30 80 year age . 2 . Patients noncardioembolic ischemic stroke 3 . Patients intracranial arterial stenosis â‰¥50 % supraclinoid internal carotid artery , M1 portion middle cerebral artery , A1 portion anterior cerebral artery , P1 portion posterior cerebral artery , basilar artery . 4 . LDLC level 100 mg/dl ( 2.6 mmol/L ) treatment dyslipidemia 5 . Patients take clopidogrel antiplatelet therapy provide informed consent 6 . Patients consider able visit study site 7 . Patients provide write informed consent 1 . Any haemorrhagic stroke haemorrhagic infarction 2 . Familial hypercholesterolemia 3 . Patients uncontrolled angina pectoris congestive heart failure 4 . Patients severe liver renal dysfunction 5 . Patients malignant tumor require treatment 6 . Patients uncontrolled diabetes mellitus 7 . Patients secondary dyslipidemia ( due corticosteroid etc ) 8 . Patients history myopathy 9 . Patients consider investigator unsuitable participating study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>intracranial arterial disease</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>rosuvastatin</keyword>
</DOC>